NASDAQ:FLGT - Fulgent Genetics Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$3.9011 +0.05 (+1.30 %)
(As of 01/21/2019 12:34 PM ET)
Previous Close$3.85
Today's Range$3.80 - $3.99
52-Week Range$3.02 - $5.56
Volume6,948 shs
Average Volume37,375 shs
Market Capitalization$70.49 million
P/E Ratio-35.46
Dividend YieldN/A
Beta0.66
Fulgent Genetics, Inc., together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. Its technology platform integrates data comparison and suppression algorithms, learning software, and genetic diagnostics tools and integrated laboratory processes. The company primarily serves hospitals and medical institutions. It markets its tests through internal sales force, as well as through independent sales representatives in the United States, Canada, the People's Republic of China, and internationally. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in Temple City, California.

Receive FLGT News and Ratings via Email

Sign-up to receive the latest news and ratings for FLGT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical laboratories
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:FLGT
CUSIPN/A
Phone626-350-0537

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$18.73 million
Book Value$3.04 per share

Profitability

Net Income$-2,510,000.00

Miscellaneous

Employees98
Market Cap$70.49 million
OptionableNot Optionable

Fulgent Genetics (NASDAQ:FLGT) Frequently Asked Questions

What is Fulgent Genetics' stock symbol?

Fulgent Genetics trades on the NASDAQ under the ticker symbol "FLGT."

How were Fulgent Genetics' earnings last quarter?

Fulgent Genetics Inc (NASDAQ:FLGT) issued its earnings results on Tuesday, November, 6th. The company reported ($0.03) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.03). The company had revenue of $5.63 million for the quarter. Fulgent Genetics had a negative return on equity of 8.51% and a negative net margin of 26.70%. View Fulgent Genetics' Earnings History.

When is Fulgent Genetics' next earnings date?

Fulgent Genetics is scheduled to release their next quarterly earnings announcement on Wednesday, February 27th 2019. View Earnings Estimates for Fulgent Genetics.

What price target have analysts set for FLGT?

2 analysts have issued 12 month price targets for Fulgent Genetics' stock. Their predictions range from $5.00 to $5.10. On average, they anticipate Fulgent Genetics' share price to reach $5.05 in the next year. This suggests a possible upside of 29.5% from the stock's current price. View Analyst Price Targets for Fulgent Genetics.

What is the consensus analysts' recommendation for Fulgent Genetics?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Fulgent Genetics in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Fulgent Genetics.

Has Fulgent Genetics been receiving favorable news coverage?

Media headlines about FLGT stock have been trending positive this week, InfoTrie Sentiment reports. InfoTrie identifies negative and positive press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Fulgent Genetics earned a news impact score of 2.7 on InfoTrie's scale. They also gave news articles about the company a news buzz of 1.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the immediate future.

Who are some of Fulgent Genetics' key competitors?

Who are Fulgent Genetics' key executives?

Fulgent Genetics' management team includes the folowing people:
  • Mr. Ming Hsieh, Chairman, CEO & Pres (Age 63)
  • Mr. Paul Kim, Chief Financial Officer (Age 52)
  • Dr. Han Lin Gao, Chief Scientific Officer & Lab Director (Age 52)
  • Joe Roach, VP

When did Fulgent Genetics IPO?

(FLGT) raised $60 million in an initial public offering on Thursday, September 29th 2016. The company issued 4,600,000 shares at a price of $12.00-$14.00 per share. Credit Suisse and Piper Jaffray served as the underwriters for the IPO and Raymond James and BTIG were co-managers.

How do I buy shares of Fulgent Genetics?

Shares of FLGT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Fulgent Genetics' stock price today?

One share of FLGT stock can currently be purchased for approximately $3.9011.

How big of a company is Fulgent Genetics?

Fulgent Genetics has a market capitalization of $70.49 million and generates $18.73 million in revenue each year. The company earns $-2,510,000.00 in net income (profit) each year or ($0.11) on an earnings per share basis. Fulgent Genetics employs 98 workers across the globe.

What is Fulgent Genetics' official website?

The official website for Fulgent Genetics is http://www.fulgentgenetics.com.

How can I contact Fulgent Genetics?

Fulgent Genetics' mailing address is 4978 SANTA ANITA AVENUE, TEMPLE CITY CA, 91780. The company can be reached via phone at 626-350-0537 or via email at [email protected]


MarketBeat Community Rating for Fulgent Genetics (NASDAQ FLGT)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  131 (Vote Outperform)
Underperform Votes:  162 (Vote Underperform)
Total Votes:  293
MarketBeat's community ratings are surveys of what our community members think about Fulgent Genetics and other stocks. Vote "Outperform" if you believe FLGT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FLGT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/21/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel